The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

Vaccine opponents and skeptics in charge of federal health agencies are restricting access to COVID shots that were a signature accomplishment of President Donald Trump’s first term.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

At the outset of the meeting, the FDA's new top vaccine regulator, Vinay Prasad, said he and FDA leaders wanted to "give people a little more time to digest the policy." He said that the FDA is still ...

A panel of advisers to the U.S. Food and Drug Administration (FDA) has recommended that for the upcoming fall and winter immunization campaigns, COVID-19 vaccine makers should formulate their shots to ...

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all ...

This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...

If I am unable to access a vaccine in the future and get a nasty case of COVID, I'll know where to point the finger and so will millions of others.